Although the pancreatic cancer pathway appears not to be associated with breast cancer, some reports have determined that mutations in the BRCA2 gene have been implicated in pancreatic cancer susceptibility through studies conducted on high-risk breast and ovarian cancer families. This evidence concerns the gene BRCA2 and ovarian cancer.